UNSPSC 51152001: Atracurium

This classification denotes a neuromuscular blocking agent with the molecular formula C65H82N2O18S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40AX66P76P, chemically known as benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate but generally known as atracurium besylate, which bears US NIH Compound Identifier 47320.

UNSPSC 51152001 Atracurium, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026—solicits naloxone and drug deactivation systems, not atracurium (a neuromuscular blocking agent used in anesthesia). This mismatch suggests the code may be incorrectly tagged in the state and local procurement system or that atracurium procurement does not materialize in posted solicitations at the state and local level with sufficient frequency to establish a pattern of buying activity.

Seminole County's opportunity, an IFB with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors were required to submit bids electronically, include all shipping and delivery costs, and comply with E-Verify and drug-free workplace certification. The contract offered a two-year initial term with an optional one-year renewal and was potentially funded through FEMA, introducing additional federal compliance requirements. Without additional recent opportunities under this code that actually address atracurium procurement, the code presents limited visibility into genuine state and local demand for this pharmaceutical product.